Samaras Nikolaos, Papadopoulou Maria-Aikaterini, Samaras Dimitrios, Ongaro Filippo
Clinique Générale Beaulieu, Geneva, Switzerland.
Department of Internal Medicine, Rehabilitation and Geriatrics, Geneva University Hospitals, Geneva, Switzerland.
Clin Interv Aging. 2014 Jul 23;9:1175-86. doi: 10.2147/CIA.S48918. eCollection 2014.
Given demographic evolution of the population in modern societies, one of the most important health care needs is successful aging with less frailty and dependency. During the last 20 years, a multitude of anti-aging practices have appeared worldwide, aiming at retarding or even stopping and reversing the effects of aging on the human body. One of the cornerstones of anti-aging is hormone replacement. At present, women live one third of their lives in a state of sex-hormone deficiency. Men are also subject to age-related testosterone decline, but andropause remains frequently under-diagnosed and under-treated. Due to the decline of hormone production from gonads in both sexes, the importance of dehydroepiandrosterone (DHEA) in steroid hormone production increases with age. However, DHEA levels also decrease with age. Also, growth hormone age-associated decrease may be so important that insulin growth factor-1 levels found in elderly individuals are sometimes as low as those encountered in adult patients with established deficiency. Skin aging as well as decreases in lean body mass, bone mineral density, sexual desire and erectile function, intellectual activity and mood have all been related to this decrease of hormone production with age. Great disparities exist between recommendations from scientific societies and actual use of hormone supplements in aging and elderly patients. In this article, we review actual data on the effects of age related hormone decline on the aging process and age-related diseases such as sarcopenia and falls, osteoporosis, cognitive decline, mood disorders, cardiovascular health and sexual activity. We also provide information on the efficiency and safety of hormone replacement protocols in aging patients. Finally, we argue on future perspectives of such protocols as part of everyday practice.
鉴于现代社会人口的人口结构演变,最重要的医疗保健需求之一是成功老龄化,减少虚弱和依赖。在过去20年里,全球出现了大量抗衰老实践,旨在延缓甚至阻止和逆转衰老对人体的影响。抗衰老的基石之一是激素替代。目前,女性一生中有三分之一的时间处于性激素缺乏状态。男性也会出现与年龄相关的睾酮水平下降,但雄激素缺乏症仍经常被漏诊和治疗不足。由于两性性腺激素分泌的减少,脱氢表雄酮(DHEA)在类固醇激素生成中的重要性随年龄增长而增加。然而,DHEA水平也会随年龄下降。此外,生长激素与年龄相关的下降可能非常显著,以至于老年人中发现的胰岛素生长因子-1水平有时低至成年确诊缺乏患者的水平。皮肤老化以及瘦体重、骨矿物质密度、性欲和勃起功能、智力活动和情绪的下降都与激素分泌随年龄的减少有关。科学协会的建议与衰老和老年患者激素补充剂的实际使用之间存在巨大差异。在本文中,我们回顾了关于年龄相关激素下降对衰老过程和与年龄相关疾病(如肌肉减少症和跌倒、骨质疏松症、认知衰退、情绪障碍、心血管健康和性活动)影响的实际数据。我们还提供了衰老患者激素替代方案的有效性和安全性信息。最后,我们讨论了此类方案作为日常实践一部分的未来前景。